SV2A and Alzheimer disease: In Alzheimer’s disease patients, PET imaging with different SV2A tracers revealed a decreased binding in several cortical areas, thalamus (Bastin et al., 2020) and hippocampus (Chen et al., 2018; Bastin et al., 2020).